BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38074506)

  • 1. Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.
    Llaneras J; Ruiz-Cobo JC; Rando-Segura A; Barreira-Díaz A; Domínguez-Hernández R; Rodríguez-Frías F; Campins M; Colom J; Casado MA; Blanco-Grau A; Bañares J; Monforte A; Falcó-Roget A; Ruíz L; Meza B; Pumarola T; Riveiro-Barciela M; Esteban R; Buti M
    JHEP Rep; 2024 Jan; 6(1):100932. PubMed ID: 38074506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom.
    Williams J; Vickerman P; Douthwaite S; Nebbia G; Hunter L; Wong T; Ruf M; Miners A
    Value Health; 2020 Aug; 23(8):1003-1011. PubMed ID: 32828211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency department targeted screening for hepatitis C does not improve linkage to care.
    Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
    World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom.
    Williams J; Vickerman P; Smout E; Page EE; Phyu K; Aldersley M; Nebbia G; Douthwaite S; Hunter L; Ruf M; Miners A
    Cost Eff Resour Alloc; 2022 Nov; 20(1):60. PubMed ID: 36376920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
    Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
    Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
    Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
    PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern.
    Brouard C; Parenton F; Youssouf H; Chevaliez S; Gordien E; Jean M; Bruyand M; Vaux S; Lot F; Ruello M;
    BMC Infect Dis; 2022 Aug; 22(1):716. PubMed ID: 36038821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
    Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
    Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth cohort-specific consideration in an Emergency Department Hepatitis C Testing Programme: A description of age-related characteristics and outcomes.
    Walter LA; Prados M; Lloyd A; Sontheimer S; Heimann M; Rodgers JB; Hand DT; Franco R
    J Viral Hepat; 2024 May; 31(5):233-239. PubMed ID: 38366787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a need for universal double reflex testing of HBsAg-positive individuals for hepatitis D infection?
    Abbas Z; Abbas M
    World J Hepatol; 2024 Mar; 16(3):300-303. PubMed ID: 38577532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?
    Alvarado-Mora MV; Fernandez MF; Gomes-Gouvêa MS; de Azevedo Neto RS; Carrilho FJ; Pinho JR
    PLoS One; 2011 Apr; 6(4):e18888. PubMed ID: 21559488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C.
    Rowan SE; Haukoos J; Kamis KF; Hopkins E; Gravitz S; Lyle C; Al-Tayyib AA; Gardner EM; Galbraith JW; Hsieh YH; Lyons MS; Rothman RE; White DAE; Morgan JR; Linas BP; Sabel AL; Wyles DL;
    Trials; 2023 Jan; 24(1):63. PubMed ID: 36707909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating hepatitis C virus screening of baby boomers at a community hospital emergency department.
    Wu G; Zhou A; Kwon S
    J Viral Hepat; 2022 Apr; 29(4):263-270. PubMed ID: 35152523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of blood-borne viral infections in Afghanistan.
    Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
    Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.